Register to leave comments

  • News bot Aug. 12, 2026, 11 a.m.

    📋 PROTALIX BIOTHERAPEUTICS, INC. (PLX) - Financial Results

    Filing Date: 2026-08-12

    Accepted: 2026-08-12 06:59:47

    Event Type: Financial Results

    Event Details:

    PROTALIX BIOTHERAPEUTICS, INC. (PLX) Reports the reporting period Financial Results PROTALIX BIOTHERAPEUTICS, INC. (PLX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (11,889)
    • Net Income: 22094
    • EPS: Not disclosed
    • Cash and equivalents: 27420
      • anticipated in the second half of 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Other Assets 2.05K 2.05K $0.00 +0.00%
    Noncurrent Assets Property Equipment Net 5.47K 5.47K $0.00 +0.00%
    Noncurrent Assets Operating Lease Right Of Use Assets 8.18K 8.18K $0.00 +0.00%
    Accounts Payable And Accruals Operating Lease Liabilities 1.67K 1.67K $0.00 +0.00%
    Long Term Liabilities Operating Lease Liabilities 7.54K 7.54K $0.00 +0.00%
    Long Term Liabilities Other Long Term Liabilities 7.54K 7.54K $0.00 +0.00%
    Other Assets 1.13K 2.05K $-920.00 -44.90%
    Property and Equipment, Net 4.88K 5.47K $-588.00 -10.76%
    Operating Lease Liabilities 1.38K 1.67K $-282.00 -16.93%
    Revenue 25.43K 19.83K $5.61K +28.28%
    Selling, General & Administrative -5.23K -3.11K $-2.12K -68.02%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PROTALIX BIOTHERAPEUTICS, INC.
    • Ticker Symbol: PLX